QMS Medical Allied Services DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025


0.73×	0.72×	0.73×
0.76×	0.75×	0.86×
12.9%	12.7%	13.8%
0.86×	0.86×	0.82×
12.3%	12.3%	15.3%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

QMSMEDI₹177.18

QMS Medical Allied Services Limited

· Pharma & Health

₹ CroreMcap ₹343 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.73	0.72	0.73
Interest Burden (Pretax/EBIT) ×	0.86	0.75	0.76
EBIT Margin %	13.83	12.69	12.92
Asset Turnover ×	0.82	0.86	0.86
ROE (owners' profit / average owners' equity) %	15.27	12.29	12.29

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.